Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Exchange Rates
Interest Rates
Futures
Economy
Global Metrics

Myovant Sciences Shares Outstanding 2017-2019 | MYOV

Myovant Sciences shares outstanding from 2017 to 2019. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
  
Myovant Sciences Annual Shares Outstanding
(Millions of Shares)
2019 67
2018 60
2017 49
2016 37
Myovant Sciences Quarterly Shares Outstanding
(Millions of Shares)
Q1 2019 76
Q4 2019 67
Q3 2018 68
Q2 2018 67
Q1 2018 63
Q4 2018 60
Q3 2017 60
Q2 2017 59
Q1 2017 59
Q4 2017 49
Q3 2016 54
Q2 2016 43
Q1 2016 41
Q4 2016
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.543B $0.000B
Myovant Sciences Ltd. is a biopharmaceutical company. It focused on developing and commercializing therapies for women's health diseases and other endocrine-related disorders, including advanced prostate cancer. The company's product candidate consists of relugolix which are in clinical trial, an oral once-daily small molecule that acts as a gonadotropin-releasing hormone receptor antagonist. Myovant Sciences Ltd. is based in Hamilton, Bermuda.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $117.332B 13.36
Gilead Sciences (GILD) United States $83.535B 10.26
CSL (CSLLY) Australia $72.754B 0.00
Celgene (CELG) United States $70.130B 10.85
Vertex Pharmaceuticals (VRTX) United States $45.274B 48.93
Illumina (ILMN) United States $44.864B 52.71
Biogen (BIIB) United States $43.459B 7.72
Regeneron Pharmaceuticals (REGN) United States $31.428B 14.27
Actelion (ALIOF) Switzerland $29.891B 0.00
Alexion Pharmaceuticals (ALXN) United States $23.694B 12.49
SINO PHARMACEUT (SBMFF) China $17.812B 0.00
Incyte (INCY) United States $16.801B 49.44
BioMarin Pharmaceutical (BMRN) United States $13.639B 0.00
Exact Sciences (EXAS) United States $13.389B 0.00
Genmab (GNMSF) Denmark $12.505B 70.14
Seattle Genetics (SGEN) United States $11.770B 0.00
Bio-Rad Laboratories (BIO.B) United States $9.952B 53.35
Alnylam Pharmaceuticals (ALNY) United States $9.408B 0.00
Galapagos (GLPG) Belgium $8.713B 0.00
QIAGEN (QGEN) Netherlands $7.627B 25.05
Bio-Techne Corp (TECH) United States $7.484B 51.70
Guardant Health (GH) United States $6.751B 0.00
Sarepta Therapeutics (SRPT) United States $6.346B 0.00
BeiGene (BGNE) Cayman Islands $6.313B 0.00
Amarin (AMRN) Ireland $6.051B 0.00
ACADIA Pharmaceuticals (ACAD) United States $6.022B 0.00
Exelixis (EXEL) United States $5.928B 15.41
Moderna (MRNA) United States $5.910B 0.00
Bluebird Bio (BLUE) United States $5.863B 0.00
Horizon Pharma Public (HZNP) Ireland $4.941B 12.56
ARGENX SE-ADR (ARGX) Netherlands $4.817B 0.00
Ascendis Pharma (ASND) Denmark $4.538B 0.00
China Biologic Products (CBPO) China $4.487B 28.01
Repligen (RGEN) United States $4.247B 82.41
Spark Therapeutics (ONCE) United States $3.926B 0.00
Blueprint Medicines (BPMC) United States $3.900B 0.00
Medicines (MDCO) United States $3.824B 0.00
MorphoSys AG (MOR) Germany $3.702B 0.00
Mirati Therapeutics (MRTX) United States $3.615B 0.00
Alkermes (ALKS) Ireland $3.334B 0.00
Immunomedics (IMMU) United States $3.273B 0.00
Reata Pharmaceuticals (RETA) United States $2.764B 0.00
Emergent Biosolutions (EBS) United States $2.686B 40.35
MyoKardia (MYOK) United States $2.668B 0.00
Genomic Health (GHDX) United States $2.640B 49.51
CRISPR Therapeutics AG (CRSP) Switzerland $2.597B 0.00
Arena Pharmaceuticals (ARNA) United States $2.551B 5.48
Ultragenyx Pharmaceutical (RARE) United States $2.502B 0.00
Amicus Therapeutics (FOLD) United States $2.450B 0.00
Halozyme Therapeutics (HALO) United States $2.383B 0.00
Acceleron Pharma (XLRN) United States $2.281B 0.00
Intercept Pharmaceuticals (ICPT) United States $2.264B 0.00
NeoGenomics (NEO) United States $2.263B 121.06
Akcea Therapeutics (AKCA) United States $2.090B 0.00
Myriad Genetics (MYGN) United States $2.066B 21.68
Cambrex (CBM) United States $2.007B 25.37
Zai Lab (ZLAB) China $1.995B 0.00
Ligand Pharmaceuticals (LGND) United States $1.990B 25.17
UniQure (QURE) Netherlands $1.795B 0.00
Denali Therapeutics (DNLI) United States $1.745B 0.00
Insmed (INSM) United States $1.742B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $1.621B 0.00
Alder BioPharmaceuticals (ALDR) United States $1.561B 0.00
REGENXBIO (RGNX) United States $1.451B 0.00
Coherus BioSciences (CHRS) United States $1.435B 0.00
Orchard Therapeutics (ORTX) United Kingdom $1.395B 0.00
Momenta Pharmaceuticals (MNTA) United States $1.315B 0.00
Alector (ALEC) United States $1.273B 0.00
Editas Medicine (EDIT) United States $1.247B 0.00
Sangamo Therapeutics (SGMO) United States $1.230B 0.00
RA PHARMCTL INC (RARX) United States $1.183B 0.00
Fate Therapeutics (FATE) United States $1.168B 0.00
AnaptysBio (ANAB) United States $1.129B 0.00
Innoviva (INVA) United States $1.111B 3.21
Athenex (ATNX) United States $1.089B 0.00
Zymeworks (ZYME) Canada $1.031B 0.00
Epizyme (EPZM) United States $1.015B 0.00
Dicerna Pharmaceuticals (DRNA) United States $0.986B 0.00
Cara Therapeutics (CARA) United States $0.918B 0.00
Twist Bioscience (TWST) United States $0.904B 0.00
ANI Pharmaceuticals (ANIP) United States $0.879B 14.69
BAVARIAN NORDIC (BVNRY) Denmark $0.875B 0.00
Codexis (CDXS) United States $0.856B 0.00
WAVE Life Sciences (WVE) Singapore $0.850B 0.00
Arvinas (ARVN) United States $0.828B 0.00
Principia Biopharma (PRNB) United States $0.821B 427.88
Pharming Group (PHGUF) Netherlands $0.811B 0.00
Cytokineticsorporated (CYTK) United States $0.773B 0.00
Zealand Pharma (ZEAL) Denmark $0.766B 8.88
UROGEN PHARMA (URGN) United States $0.742B 0.00
Anika Therapeutics (ANIK) United States $0.741B 26.21
ZIOPHARM Oncology Inc (ZIOP) United States $0.733B 0.00
Zealand Pharma (ZLDPF) Denmark $0.723B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.719B 25.96
Intellia Therapeutics (NTLA) United States $0.704B 0.00
Vericel (VCEL) United States $0.701B 0.00
Mesoblast (MESO) Australia $0.684B 0.00
Revance Therapeutics (RVNC) United States $0.621B 0.00
MiMedx (MDXG) United States $0.601B 0.00
DBV Technologies S.A (DBVT) France $0.581B 0.00
Heska (HSKA) United States $0.557B 72.15
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.532B 0.00
Retrophin (RTRX) United States $0.532B 0.00
Achillion Pharmaceuticals (ACHN) United States $0.528B 0.00
Precision BioSciences (DTIL) United States $0.509B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.505B 0.00
Cellectis S.A (CLLS) France $0.503B 0.00
Stemline Therapeutics (STML) United States $0.495B 0.00
Intra-Cellular Therapies (ITCI) United States $0.482B 0.00
PHARMA MAR SA (PHMMF) Spain $0.468B 0.00
Sinovac Biotech (SVA) China $0.460B 0.00
Syros Pharmaceuticals (SYRS) United States $0.460B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.440B 0.00
Merus (MRUS) Netherlands $0.438B 0.00
Puma Biotechnology (PBYI) United States $0.434B 0.00
BioDelivery Sciences (BDSI) United States $0.420B 0.00
Agenus (AGEN) United States $0.417B 0.00
CytomX Therapeutics (CTMX) United States $0.417B 0.00
Arcus Biosciences (RCUS) United States $0.414B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.409B 0.00
Bellus Health (BLU) Canada $0.407B 0.00
Adverum Biotechnologies (ADVM) United States $0.398B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.367B 0.00
Protagonist Therapeutics (PTGX) United States $0.362B 0.00
AC Immune SA (ACIU) Switzerland $0.362B 26.80
Kadmon Holdings (KDMN) United States $0.350B 0.00
Gritstone Oncology (GRTS) United States $0.349B 0.00
Theratechnologies (THERF) Canada $0.340B 0.00
Prothena (PRTA) Ireland $0.340B 0.00
Avid Bioservices (CDMO) United States $0.331B 0.00
Scholar Rock Holding (SRRK) United States $0.323B 0.00
Biofrontera AG (BFRA) Germany $0.312B 466.67
ADMA Biologics Inc (ADMA) United States $0.311B 0.00
Kindred Biosciences (KIN) United States $0.301B 0.00
Sorrento Therapeutics (SRNE) United States $0.299B 0.00
Albireo Pharma (ALBO) United States $0.297B 0.00
Starpharma Holdings (SPHRY) Australia $0.295B 0.00
Cellular Biomedicine (CBMG) United States $0.287B 0.00
Dynavax Technologies (DVAX) United States $0.287B 0.00
Geron (GERN) United States $0.271B 0.00
Seres Therapeutics (MCRB) United States $0.270B 0.00
Clovis Oncology (CLVS) United States $0.266B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.261B 0.00
Senesco Technologies (ELOX) United States $0.253B 0.00
MannKind (MNKD) United States $0.250B 0.00
ChromaDex (CDXC) United States $0.247B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.247B 0.00
Prometic Life Sciences (PFSCF) Canada $0.246B 0.00
PDL BioPharma (PDLI) United States $0.246B 6.32
Sutro Biopharma (STRO) United States $0.245B 0.00
Inovio Pharmaceuticals (INO) United States $0.241B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.238B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.236B 0.00
POXEL SA FRANCE (PXXLF) France $0.228B 0.00
Affimed (AFMD) Germany $0.226B 0.00
Spero Therapeutics (SPRO) United States $0.226B 0.00
Compugen (CGEN) Israel $0.222B 0.00
Athersys (ATHX) United States $0.221B 0.00
EXICURE INC (XCUR) United States $0.219B 0.00
Kamada (KMDA) Israel $0.207B 7.89
Five Prime Therapeutics (FPRX) United States $0.200B 0.00
Cue Biopharma (CUE) United States $0.199B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.197B 0.00
OSMOTICA PHARM (OSMT) United States $0.185B 0.00
Arsanis (XFOR) United States $0.183B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.183B 0.00
XOMA (XOMA) United States $0.179B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.179B 0.00
Alcobra (ARCT) United States $0.176B 0.00
Nicox SA (NICXF) France $0.173B 0.00
Enzo Biochem (ENZ) United States $0.170B 0.00
Newron Pharmaceuticals SpA (NWPHF) $0.165B 0.00
Acorda Therapeutics (ACOR) United States $0.163B 0.00
Dyadic (DYAI) United States $0.162B 0.00
Novavax (NVAX) United States $0.161B 0.00
Abeona Therapeutics (ABEO) United States $0.160B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.154B 0.00
Strongbridge Biopharma (SBBP) United States $0.148B 6.09
Cerecor (CERC) United States $0.143B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.143B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.143B 0.00
Northwest Biotherapeutics (NWBO) United States $0.143B 0.00
Adocia (ADOCY) France $0.140B 0.00
PHASEBIO PHARMA (PHAS) United States $0.139B 0.00
Emmaus Life Sciences (EMMA) United States $0.131B 0.00
NantKwest (NK) United States $0.130B 0.00
Windtree Therapeutics (WINT) United States $0.129B 0.00
Aptinyx (APTX) United States $0.126B 0.00
Menlo Therapeutics (MNLO) United States $0.120B 0.00
Fortress Biotech (FBIO) United States $0.115B 0.00
SESEN BIO, INC (SESN) United States $0.110B 0.00
Celyad SA (CYAD) Belgium $0.101B 0.00
Aduro Biotech (ADRO) United States $0.098B 0.00
Vaccinex (VCNX) United States $0.097B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.097B 0.00
Verastem (VSTM) United States $0.096B 0.00
OvaScience (MLND) United States $0.093B 0.00
Trevena (TRVN) United States $0.093B 0.00
ARAVIVE, INC (ARAV) United States $0.091B 0.00
Arbutus Biopharma (ABUS) Canada $0.091B 0.00
Mersana Therapeutics (MRSN) United States $0.088B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.088B 0.00
VTv Therapeutics (VTVT) United States $0.086B 0.00
Checkpoint Therapeutics (CKPT) United States $0.083B 0.00
Idera Pharmaceuticals (IDRA) United States $0.082B 0.00
Selecta Biosciences (SELB) United States $0.082B 0.00
Synlogic (SYBX) United States $0.081B 0.00
Antibe Therapeutics (ATBPF) Canada $0.080B 0.00
Aquinox Pharmaceuticals (NLTX) Canada $0.079B 0.00
Curis (CRIS) United States $0.075B 0.00
Liquidia Technologies (LQDA) United States $0.075B 0.00
Merrimack Pharmaceuticals (MACK) United States $0.074B 0.00
NewLink Genetics (NLNK) United States $0.071B 0.00
Catalyst Biosciences (CBIO) United States $0.070B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.070B 0.00
Orgenesis (ORGS) United States $0.068B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.068B 0.00
Pluristem Therapeutics (PSTI) Israel $0.066B 0.00
Applied Genetic Technologies (AGTC) United States $0.066B 36.10
ASLAN Pharmaceuticals (ASLN) Singapore $0.063B 0.00
Spring Bank Pharmaceuticals (SBPH) United States $0.061B 0.00
AquaBounty Technologies (AQB) United States $0.061B 0.00
Prima BioMed (IMMP) Australia $0.059B 0.00
Unum Therapeutics (UMRX) United States $0.059B 0.00
Stellar Biotechnologies (EDSA) Canada $0.056B 0.00
VistaGen Therapeutics (VTGN) United States $0.051B 0.00
AIT Therapeutics (XAIR) United States $0.050B 0.00
Proteostasis Therapeutics (PTI) United States $0.049B 0.00
VBI Vaccines (VBIV) United States $0.048B 0.00
Oncobiologics (OTLK) United States $0.047B 0.00
Ophthotech (ISEE) United States $0.046B 0.00
Vascular Biogenics (VBLT) Israel $0.046B 0.00
VIVUS (VVUS) United States $0.044B 0.00
Evogene (EVGN) Israel $0.043B 0.00
INNOVATE BIOPHARMACEUTICALS, INC (INNT) United States $0.041B 0.00
Celldex Therapeutics (CLDX) United States $0.038B 0.00
Organovo Holdings (ONVO) United States $0.037B 0.00
BIOCARDIA INC (BCDA) United States $0.037B 0.00
Celsion (CLSN) United States $0.036B 0.00
DiaMedica Therapeutics (DMAC) United States $0.034B 0.00
Alimera Sciences (ALIM) United States $0.033B 0.00
Aptevo Therapeutics (APVO) United States $0.030B 0.00
Entera Bio (ENTX) Israel $0.030B 0.00
Fibrocell Science Inc (FCSC) United States $0.028B 9.73
Aerpio Pharmaceuticals (ARPO) United States $0.028B 0.00
Signal Genetics (MGEN) United States $0.028B 0.00
Clearside Biomedical (CLSD) United States $0.028B 0.00
AEterna Zentaris (AEZS) United States $0.027B 0.00
Apricus Biosciences (SEEL) United States $0.027B 0.00
Caladrius Biosciences (CLBS) United States $0.025B 0.00
Aytu Bioscience (AYTU) United States $0.023B 0.00
Novogen (KZIA) Australia $0.021B 0.00
Novelion Therapeutics (NVLN) Canada $0.020B 0.00
TOCAGEN INC (TOCA) United States $0.019B 0.00
Soligenix (SNGX) United States $0.019B 0.00
Prana Biotechnology (ATHE) Australia $0.017B 0.00
Pulmatrix (PULM) United States $0.017B 0.00
CollPlant Holdings (CLGN) Israel $0.015B 0.00
MYOS RENS Technology (MYOS) United States $0.015B 0.00
TRACON Pharmaceuticals (TCON) United States $0.014B 0.00
Cleveland BioLabs (CBLI) United States $0.012B 0.00
TrovaGene (TROV) United States $0.010B 0.00
IMMURON (IMRN) Australia $0.010B 0.00
Bionano Genomics (BNGO) United States $0.009B 0.00
Genetic Technologies (GENE) Australia $0.009B 0.00
Benitec Biopharma (BNTC) Australia $0.009B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.007B 0.00
Titan Pharmaceuticals (TTNP) United States $0.006B 0.00
Advaxis (ADXS) United States $0.005B 0.00
Neuralstem (CUR) United States $0.004B 0.00